Image 1
Chemical structure of fluvastatin sodium, depicting the molecular arrangement including a fluorophenyl group, hydroxy groups, and a sodium ion.*
Fluvastatin Capsule
Product Images NDC 0093-7443
7 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 0093-7443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
A Kaplan-Meier survival curve graph comparing the percentage of patients without events over time between Fluvastatin 80 mg and placebo groups. The x-axis represents years since randomization, and the y-axis shows the percentage of patients without events. Statistical values including Cox P-Value, Log-Rank P-Value, and Hazard Ratio with confidence intervals are included.*
Image 3
A clinical data forest plot chart depicting the incidence and risk reduction of various cardiac and secondary endpoints comparing Fluvastatin to placebo. The chart includes events like recurrent cardiac events, cardiac death, myocardial infarction, and revascularization, with risk reduction percentages and Cox risk ratios illustrated by horizontal bars and squares. It visually presents confidence intervals and favorability between Fluvastatin and placebo groups.*
Image 4
A bar graph displaying the change in minimum lumen diameter (mm) comparing Fluvastatin and placebo across three patient groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). Each group shows two bars representing Fluvastatin and placebo with associated p-values.*
Image 5
A bar chart showing the change in percent diameter stenosis comparing Fluvastatin versus placebo across three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). The chart includes sample sizes and p-values indicating statistical comparisons for each group.*
Image 6
Label for Fluvastatin Capsules, USP 20 mg by Teva Pharmaceuticals USA, Inc. The label includes the NDC 0093-7442-01 and states the package contains 100 capsules. It provides storage instructions and a pharmacist notice to dispense the Patient Information Leaflet with each prescription.*
Image 7
Fluvastatin Capsules, USP 40 mg oral capsules label by Teva Pharmaceuticals USA, Inc. The label indicates the product contains 100 capsules, with the 40 mg strength displayed prominently. The label includes usage instructions, storage conditions, barcode, and serialization coding area. Manufacturer details include Ranbaxy Pharmaceuticals USA and other associated entities.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
